Loading organizations...
§ Private Profile · 15th Main J P Nagar 6th Phase, Bengaluru, Karnataka, 560002, India
A deep-tech SaaS company that offers software to optimize molecular testing & diagnostics through algorithmic pooling.
Algorithmic Biologics is a Bengaluru, India-based deep-tech company that develops software-as-a-service solutions to optimize molecular testing and diagnostics workflows for healthcare laboratories. The B2B platform utilizes advanced algorithms and multiplexing techniques to enable efficient sample pooling, which significantly reduces the time, chemical reagents, and financial costs associated with complex diagnostic processes like RT-PCR and Next-Generation Sequencing. Operating within the healthcare, genomics, and agricultural biotechnology sectors, the enterprise successfully secured $2.5 million in a January 2024 Pre-Series A funding round. This strategic capital injection was led by Bharat Innovation Fund, with additional equity participation from venture capital firms Axilor Ventures and SeaFund. The company recently expanded the commercial application of its flagship software product, Tapestry, transitioning from initial COVID-19 testing applications to broader genomic sequencing and molecular diagnostic capabilities. Algorithmic Biologics was founded in 2021 by Manoj Gopalkrishnan.
Algorithmic Biologics has raised $2.0M across 1 funding round.
Algorithmic Biologics has raised $2.0M in total across 1 funding round.
Algorithmic Biologics has raised $2.0M in total across 1 funding round.
Algorithmic Biologics's investors include Bharat Innovation Fund, Axilor Ventures, Som.
Algorithmic Biologics is a Bengaluru-based deep-tech startup founded in 2021, specializing in biotechnology and healthtech by developing computational platforms for biological data analysis and molecular testing workflows.[1][2][3] The company builds software that applies advanced algorithmic innovations to enhance molecular analysis, serving biotech researchers, labs, and healthtech firms facing inefficiencies in data-heavy biological processes; it has raised over $2M in funding and employs 11 people, indicating early growth momentum in a high-potential sector.[1][3]
Algorithmic Biologics was established in 2021 in Bengaluru, Karnataka, India, by Manoj Gopalkrishnan, whose background likely draws from computational biology expertise given the company's focus on algorithmic tools for biotech.[1] The idea emerged from the need for deep-tech solutions in molecular analysis, positioning it as a funded healthtech startup quick to secure investment amid rising demand for computational biology platforms.[2][3] Early traction includes raising $2M+ in funding, enabling a small but specialized team to build out its software platform.[3]
Algorithmic Biologics rides the wave of computational biology and AI-driven drug discovery, where exploding biological datasets demand faster analysis tools amid trends like precision medicine and personalized therapies.[1][2] Timing aligns with post-2021 biotech funding surges in India, fueled by global needs for efficient molecular workflows during health crises and genomic advancements.[3] Market forces like India's growing healthtech ecosystem and algorithmic scalability favor it, influencing the startup scene by bridging software with biotech R&D for quicker insights.[1]
Next steps likely involve platform scaling, deeper AI integrations for molecular predictions, and partnerships with pharma giants to accelerate testing pipelines. Trends like multimodal biological data fusion and regulatory pushes for computational validation will shape its path, potentially evolving it into a key enabler of next-gen biotech innovation. As a nimble Bengaluru player with solid early funding, it exemplifies how algorithmic biologics can transform data overload into discovery speed, echoing its origins in computational ingenuity.[1][2][3]
Algorithmic Biologics has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2024 | $2M Seed | Bharat Innovation Fund | Axilor Ventures, SOM | Announced |